Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109876 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A NA study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00109876: Completed NA study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00109876 is a NA study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00109876, a NA study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well radiofrequency ablation works in treating patients with stage IA non-small cell lung cancer. Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Computed tomography (CT)-guided radiofrequency ablation may be a better treatment for non-small cell lung cancer.
Primary Outcome
Percentage of participants who were alive at 2 years. The 2 year survival was estimated using the Kaplan Meier method.
Interventions
- PROCEDURE Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-09 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT00109876 record still lists
NCT00109876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation is the first listed.
NCT00109876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00109876 about?
NCT00109876 is a clinical study titled "Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer". This pilot clinical trial studies how well radiofrequency ablation works in treating patients with stage IA non-small cell lung cancer. Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Computed tomography (CT)-guided radiofrequency ablation may be a better treatment ...
What is the current status of trial NCT00109876?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2006-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00109876?
The interventions under investigation include: Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00109876?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00109876's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia